This inventor holds 3 USPTO granted patents. Top assignee: Unichem Laboratories Limited. Active years: 2021-2022.
Location History:
- Maharashtra, IN (2021)
- Pune, IN (2022)
- Mumbai Maharashtra, IN (2022)
Company Filing History:
Years Active: 2021-2022
Title: Pravin Kumar Maurya: Innovator in Pharmaceutical Compositions
Introduction
Pravin Kumar Maurya is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions. With a total of 3 patents to his name, Maurya's work is recognized for its impact on drug formulation and delivery.
Latest Patents
Maurya's latest patents include a pharmaceutical composition of apixaban. This invention relates to a stable, reproducible, and bioequivalent apixaban composition, which features a particle size of more than 100 microns, preferably between 300 and 1000 microns. The composition also includes one or more pharmaceutically acceptable excipients and outlines a process for preparation via wet granulation. Another significant patent involves pharmaceutical compositions comprising cinacalcet hydrochloride and one or more binders. This composition is designed to contain cinacalcet or its pharmaceutically acceptable salts, with specific particle size distributions and binder amounts, ensuring effective formulation.
Career Highlights
Pravin Kumar Maurya is currently associated with Unichem Laboratories Limited, where he continues to innovate in pharmaceutical research and development. His expertise in drug formulation has positioned him as a key player in the industry, contributing to advancements that enhance therapeutic efficacy.
Collaborations
Maurya has collaborated with notable colleagues, including Dhananjay Govind Sathe and Srikant V Pimple. These collaborations have fostered a productive environment for innovation and have led to the successful development of various pharmaceutical products.
Conclusion
Pravin Kumar Maurya's contributions to pharmaceutical compositions demonstrate his commitment to advancing healthcare through innovation. His patents reflect a deep understanding of drug formulation, which continues to benefit the pharmaceutical industry.